2L
SBBP

22NW LP’s Strongbridge Biopharma plc. SBBP Stock Holding History

22NW LP’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-804,410
Closed -$1.92M – 35
2019
Q3 		$1.92M Hold
804,410
– – 2.54% 16
2019
Q2 		$2.52M Buy
804,410
+400,000
+99% +$1.47M 2.73% 16
2019
Q1 		$2.01M Hold
404,410
– – 1.4% 28
2018
Q4 		$1.81M Buy
+404,410
New +$1.97M 1.13% 33

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

22NW LP's SBBP Position: Q4 2019 in Review

22NW LP sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2019, closing a stake of 804,410 shares — an estimated $1.92M sold.

22NW LP first reported a position in SBBP in Q4 2018 and held it in 4 quarters. The position peaked at $2.52M in Q2 2019. 58 funds tracked by Wall St. Rank hold SBBP as of Q4 2019.

  • 22NW LP reported no remaining Strongbridge Biopharma plc. position as of Q4 2019 after selling out during the quarter.
  • 22NW LP sold 804,410 Strongbridge Biopharma plc. shares in Q4 2019, an estimated $1.92M.
  • 22NW LP first reported a position in Strongbridge Biopharma plc. in Q4 2018 and held it in 4 quarters.
  • 22NW LP's Strongbridge Biopharma plc. position peaked at $2.52M in Q2 2019.
  • 58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2019.

Based on 22NW LP's 13F filing for Q4 2019, filed 14 Feb 2020.